This proposal is based upon recent data obtained during a visit to the Weizmann Institute, Rehovot, Israel. These data suggested that T lymphocyte lines from different rat strains recognized different regions of the myelin basic protein molecule, and that the recognition pattern was dictated by the antigen presenting cell. The dominant region of BP for each strain was able to stimulate T cell reactivity which induced paralytic disease (EAE) as well as protection from subsequent induction of disease. Because BP may be relevant neuroantigen in human paralytic diseases such as multiple sclerosis (MS), and because responsiveness to regions of BP could be regulated by the major histocompatibility complex (MHC), we propose to evaluate the immunodominant regions of BP in normal volunteers and MS patients in the context of Class II MHC antigens. This evalution will be accomplished by selecting BP specific T cell lines, cloning these lines, and then evaluting responsiveness to purified fragments of BP. The role of Class II MHC antigens will be inferred from HLA-D typing results, by stimulation of T cell clones with antigen presenting cells with partial identity in the HLA-D region, and by inhibition of HLA-DR, DP, and DQ dependent activation of T cell clones. From these data, we hope to determine 1) what regions of human BP stimulate human T cells, 2) the number of immunodominant determinants recognized by each individual, 3) whether the range and distribution of T cell responses differ in normal individuals and MS patients, and 4) whether HLA-D region gene products are associated with T cell recognition of human BP determinants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023221-03
Application #
3406459
Study Section
Neurology C Study Section (NEUC)
Project Start
1986-08-01
Project End
1989-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Buenafe, Abigail C; Andrew, Shayne; Offner, Halina et al. (2012) Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis. Immunology 135:168-79
Buenafe, Abigail C; Andrew, Shayne; Afentoulis, Michael et al. (2010) Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells. Immunology 130:114-24
Wang, Chunhe; Dehghani, Babak; Li, Yuexin et al. (2009) Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126:329-35
Vandenbark, Arthur A; Offner, Halina (2008) Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored? Immunology 125:1-13
Vandenbark, Arthur A; Abulafia-Lapid, Rivka (2008) Autologous T-cell vaccination for multiple sclerosis: a perspective on progress. BioDrugs 22:265-73
Sinha, Sushmita; Kaler, Laurie J; Proctor, Thomas M et al. (2008) IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol 180:2679-85
Vandenbark, Arthur A; Culbertson, Nicole E; Bartholomew, Richard M et al. (2008) Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology 123:66-78
Imam, Sarah A; Guyton, Mary K; Haque, Azizul et al. (2007) Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol 190:139-45
Vandenbark, Arthur A (2005) TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4+CD25+ Treg cells. Curr Drug Targets Inflamm Allergy 4:217-29
Subramanian, Sandhya; Tovey, Micah; Afentoulis, Michael et al. (2005) Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol 115:162-72

Showing the most recent 10 out of 136 publications